Melatonin: the dawning of a treatment for fibrosis?
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Fibrosis is a common occurrence following organ injury and failure. To date, there is no effective treatment for this condition. Melatonin targets numerous molecular pathways, a consequence of its antioxidant and anti‐inflammatory actions that reduce excessive fibrosis. Herein, we review the multiple protective effects of melatonin against fibrosis. There exist four major phases of the fibrogenic response including primary injury to the organ, activation of effector cells, the elaboration of extracellular matrix (ECM) and dynamic deposition. Melatonin regulates each of these phases. Additionally, melatonin reduces fibrosis levels in numerous organs. Melatonin exhibits its anti‐fibrosis effects in heart, liver, lung, kidney, and other organs. In addition, adhesions which occur following surgical procedures are also inhibited by melatonin. The information reviewed here should be significant to understanding the protective role of melatonin against fibrosis, contribute to the design of further experimental studies related to melatonin and the fibrotic response and shed light on a potential treatment for fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Gitto, E., Pellegrino, S., Gitto, P., Barberi, I., & Reiter, R. J. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00649.x · Cited by 291 · cited 1×
“Functionally, melatonin serves as a powerful direct [34, 117] and indirect antioxidant [118, 119], and has significant anti-inflammatory activity [28, 120].”
BackgroundSelf-citationLiu, Y., Zhu, H., Su, Z., Sun, C., Yin, J., Yuan, H., Sandoghchian, S., Jiao, Z., Wang, S., & Xu, H. (2012) · International Immunology · doi:10.1093/intimm/dxs056 · Cited by 110
Elbe, H., Esrefoglu, M., Vardi, N., Taslidere, E., Ozerol, E., & Tanbek, K. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327114559993 · Cited by 37 · cited 2×
“Fibrosis is always accompanied by oxidative stress, which is also inhibited by melatonin, indicating that the indole may protect against liver cirrhosis through reduction of oxidative damage [8, 9, 42, 44, 51, 52, 56, 58, 59, 73, 85, 88, 95, 96].”
Background
Cited by
Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas
Reiter, R. J., Rosales-Corral, S., Tan, D. X., Jou, M. J., Galano, A., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2609-7 · Cited by 558
Self-citationMelatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354
Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin
Hosseinzadeh, A., Kamrava, S. K., Joghataei, M. T., Darabi, R., Shakeri‐Zadeh, A., Shahriari, M., Reiter, R. J., Ghaznavi, H., & Mehrzadi, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12362 · Cited by 344
Self-citationCancer metastasis: Mechanisms of inhibition by melatonin
Su, S., Hsieh, M., Yang, W., Chung, W., Reiter, R. J., & Yang, S. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12370 · Cited by 280
Self-citationMelatonin and sirtuins: A “not-so unexpected” relationship
Mayo, J. C., Sainz, R. M., González Menéndez, P., Cepas, V., Tan, D., & Reiter, R. J. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12391 · Cited by 175
Self-citation
Metadata
- Authors
- Hu, W., Ma, Z., Jiang, S., Fan, C., Deng, C., Yan, X., Di, S., Lv, J., Reiter, R. J., & Yang, Y.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2016-01-17
- Volume
- 60
- Issue
- 2
- Pages
- 121-131
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2215718994
- Cited by
- 115
- References
- 4
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin: the dawning of a treatment for fibrosis? https://app.cochat.ai/papers/10.1111/jpi.12302
- The paper
- Hu, W., Ma, Z., Jiang, S., Fan, C., Deng, C., Yan, X., Di, S., Lv, J., Reiter, R. J., & Yang, Y. (2016). Melatonin: the dawning of a treatment for fibrosis? Journal of Pineal Research. https://doi.org/10.1111/jpi.12302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.